Abstract and Introduction Introduction Uveitis is a challenging disease. It represents a major cause of ocular morbidity worldwide. More than half of all patients with uveitis develop sight ...

Expert Rev Ophthalmol. 2013;8 (1):89-99. Summary As a result of information gleaned from OCT and FAF, the authors understanding of the pathogenesis of ocular inflammatory diseases continues to expand.

Rheumatoid arthritis (RA) is characterised by a chronic inflammatory condition of the joints, but the comorbidities of RA predominantly contribute to the reduced lifespan associated with this disease.

According to SNS Insider, the Uveitis Treatment Market was valued at USD 2.26 billion in 2023 and is projected to reach USD 4.69 billion by 2032, expanding at a CAGR of 8.47% during the forecast ...

SNS Insider Reveals Strategic Outlook for the U.S. Uveitis Treatment Market—Valued at USD 0.71 Billion in 2023—With the Nation Poised to Maintain North American Dominance Amid Rising Adoption of ...

About this study The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis ...

Uveitis is a common sight-threatening inflammatory disease with unclear pathogenesis. 1 2 A number of factors, such as genetics, age, sex, living habits and geographical distribution, have been shown ...

Braz J Med Biol Res, January 2003, Volume 36 (1) 3-12 (Review) Pathogenesis of Salmonella -induced enteritis R.L. Santos 1, R.M. Tsolis 2, A.J. Bäumler 2 and L.G. Adams 3 1 Departamento de Clínica e ...

Background Syphilitic uveitis is re-emerging alongside the systemic infection. In July 2017, an international group of uveitis-specialised ophthalmologists formed the International Ocular Syphilis ...

The researchers outlined that biologics such as adalimumab are a second-line treatment for patients with inflammation refractory to treatment. Uveitis caused by systemic infection should be treated ...